介入放射学杂志2023年4月第32卷第4期JInterventRadiol2023,Vol.32,No.4经皮射频消融与微波消融治疗肺癌有效性及安全性的Meta分析洪子强,白向豆,崔百强,成涛,吴旭升,金大成,苟云久【摘要】目的评价经皮射频消融(radiofrequencyablation,RFA)与微波消融(microwaveablation,MWA)治疗肺癌的有效性及安全性。方法计算机检索PubMed、Embase、TheCochraneLibrary、WebofScience、万方数据库、维普数据库和中国知网(CNKI)数据库,搜索建库至2022年2月公开发表的比较RFA与MWA治疗肺癌有效性及安全性的相关文献,采用ReviewManager5.4软件对文献进行Meta分析。结果共纳入10篇文献。801例患者中,RFA组379例,MWA组422例。RFA组与MWA组在总并发症(OR=1.40,95%CI:0.77~2.55,P=0.27)、完全消融率(OR=0.85,95%CI:0.39~1.83,P=0.67)、复发率(OR=1.74,95%CI:0.74~4.07,P=0.21)、3年OS的亚组分析(OR=0.71,95%CI:0.42~1.18,P=0.18)和总OS(OR=0.90,95%CI:0.70~1.16,P=0.41)方面差异无统计学意义;RFA组皮下气肿发生率低于MWA组(OR=0.20,95%CI:0.08~0.53,P=0.001);而MWA组无进展生存期(PFS)长于RFA组(OR=1.74,95%CI:1.17~2.60,P=0.006)。结论RFA与MWA治疗肺癌的有效性及安全性相近,RFA治疗的皮下气肿发生率更低,但MWA治疗的PFS更长。【关键词】射频消融;微波消融;肺癌;肺转移;系统评价;Meta分析中图分类号:R734.2文献标志码:A文章编号:1008-794X(2023)-04-0341-09Theeffectivenessandsafetyofpercutaneousradiofrequencyablationversusmicrowaveablationinthetreatmentoflungcancer:ametaanalysisHONGZiqiang,BAIXiangdou,CUIBaiqiang,CHENGTao,WUXusheng,JINDacheng,GOUYunjiu.FirstSchoolofClinicalMedicine,GansuUniversityofTraditionalChineseMedicine,Lanzhou,GansuProvince730000,ChinaCorrespondingauthor:GOUYunjiu,E-mail:gouyunjiu@163.com【Abstract】ObjectiveToevaluatetheeffectivenessandsafetyofpercutaneousradiofrequencyablation(RFA)andmicrowaveablation(MWA)inthetreatmentoflungcancer.MethodsAcomputerizedretrievalofacademicpapersconcerningthecomparisonoftheeffectivenessandsafetybetweenRFAandMWAforlungcancerfromthedatabasesofPubMed,Embase,CochraneLibrary,WebofScience,WanfangDatabaseandVIPwasconducted.Theretrievaltimep...